UnknownNot applicableNCT03589820

Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure

Studying Wilson disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Principal Investigator
Liang Peng, Doctor, O.M.D, L. Ac
Third Affiliated Hospital, Sun Yat-Sen University
Intervention
artificial liver support system(other)
Enrollment
60 enrolled
Eligibility
18-65 years · All sexes
Timeline
2018 – 2020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03589820 on ClinicalTrials.gov

Other trials for Wilson disease

Additional recruiting or active studies for the same condition.

See all trials for Wilson disease →

← Back to all trials